Lb Pharmaceuticals (LBRX) Shares Outstanding (2024 - 2026)

Lb Pharmaceuticals' Shares Outstanding history runs 3 years deep, the most recent figure standing at $28.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 11294.5% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (up 11294.5% YoY), while the FY2025 annual figure was $25.3 million, up 9953.2% from the prior year.
• Shares Outstanding was $28.7 million for Q1 2026 at Lb Pharmaceuticals, up from $25.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $28.7 million in Q1 2026 to a low of $251655.0 in Q3 2024.
• Historically, Shares Outstanding has averaged $13.3 million across 3 years, with a median of $12.8 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding soared 1168.14% in 2025, then jumped 11294.5% in 2026.
• A 3-year view of Shares Outstanding shows it stood at $251655.0 in 2024, then surged by 9953.2% to $25.3 million in 2025, then gained by 13.34% to $28.7 million in 2026.
• The last three Shares Outstanding figures came in at $28.7 million (Q1 2026), $25.3 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.